Predictive Oncology Total Assets 2010-2025 | POAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Predictive Oncology total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Predictive Oncology total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.9B
Tempus AI (TEM)	$12.8B
Doximity (DOCS)	$12.2B
Hims & Hers Health (HIMS)	$10.3B
IRhythm Technologies (IRTC)	$5.2B
Hinge Health (HNGE)	$4.6B
Privia Health (PRVA)	$2.6B
Inspire Medical Systems (INSP)	$2.6B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.6B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.4B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.4B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$651M
Veradigm (MDRX)	$498M
Zepp Health (ZEPP)	$491M
Standard BioTools (LAB)	$467M
Talkspace (TALK)	$429M
Carlsmed (CARL)	$360M
Butterfly Network (BFLY)	$360M
TruBridge (TBRG)	$289M
Outset Medical (OM)	$236M
SOPHiA GENETICS SA (SOPH)	$235M
Nyxoah SA (NYXH)	$212M
Health Catalyst (HCAT)	$205M
KORU Medical Systems (KRMD)	$193M